Page last updated: 2024-09-04

glg-v 13 and Myocardial Infarction

glg-v 13 has been researched along with Myocardial Infarction in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berlin, KD; Chen, CL; Fazekas, T; Garrison, GL; Lazzara, R; Patterson, E; Sangiah, S; Scherlag, BJ; Schubot, FD; van der Helm, D1

Other Studies

1 other study(ies) available for glg-v 13 and Myocardial Infarction

ArticleYear
Novel 3,7-diheterabicyclo[3.3.1]nonanes that possess predominant class III antiarrhythmic activity in 1-4 day post infarction dog models: X-ray diffraction analysis of 3-[4-(1H-imidazol-1-yl)benzoyl]-7-isopropyl-3,7-diazabicyclo[3.3.1]nona ne dihydroperch
    Journal of medicinal chemistry, 1996, Jun-21, Volume: 39, Issue:13

    Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Crystallography, X-Ray; Dogs; Electrophysiology; Heart Rate; Imidazoles; Lidocaine; Models, Molecular; Molecular Conformation; Molecular Structure; Myocardial Infarction; Tachycardia, Ventricular

1996